According to the initial company filings, here is what is known about EHSI:
August 2009 - name change from Oxford Funding (OXFD.pk) to Emerging Healthcare Solutions, Inc.
Address is 1240 Blalock Rd, Suite 200 (same address as recently SEC suspended sister company, GAEC.pk)
Number of Beneficial Owners: 7
Named Beneficial Owners stated in filings: 2
What they do: "EHSI is a development stage business with a unique ability to acquire life science technologies and bring them to emerging small and medium-sized companies that are struggling or needing another product line to gain market share. EHSI leverages the experience of its management team and relationships with larger companies and universities worldwide to work with clients to identify new product opportunities or services that will increase shareholder value and provide new revenue streams.
In addition to its primary goal of introducing companies to revolutionary technologies, EHSI is also able to assist companies with raising the capital necessary to implement these new technologies, via both public and private financing sources."
Management Team and technologies present to implement above stated leverages: "We have no full-time and three part-time employees. We do not have any products as of the date of this report." Kathleen Delaney - Executive Officer & Sole Director - attorney with one known experience in the industry (now defunct company - MyHealthy Access: MYHA.pk)
The company's only assets were the mortage portfolio owned by the predecessor named company, OXFD. All of these assets were sold for roughly $2 million (netting $0 after cost). From a year earlier, these assets were valued at $2.6 million according to their financials.
The company now states that it has no subsidiaries. However, the year before, it showed an acquisition of subsidiaries from related parties for 8 million shares and shows no mention in the current financials of disposition of same.
Operations Plan: "We have no cash and we rely on shareholder loans and sales of common stock to pay our operating and research and development expenses. We are currently developing our plan of operation and will disclose that plan once finalized."
Financial health: "we suffered continuing losses from previous operations of $675,873, and have an accumulated deficit during the development stage of $2,716,768 as of September 30, 2009 and a working capital deficit of $356,818 at September 30, 2009. These conditions raise substantial doubt as to our ability to continue as a going concern."
No mention of the disposition/asset sale of the "$100 million" Oxford Opportunistic Hedge Fund that was publically announced as having been "fully subscribed".
